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Hereditary	  angioedema	  (HAE)	   is	  a	  rare	  genetic	  disorder	  transmitted	  as	  an	  autosomal	  dominant	  trait,	  characterized	  by	  
reduced	   plasma	   concentration	   or	   by	   the	   presence	   of	   non-­‐functional	   C1	   esterase	   inhibitor.	   Oedema	   caused	   by	   HAE	  
mostly	   affects	   the	   skin	   and	   bowel	   and	   can	   induce	   swelling	   of	   genitalia.	   Oedema	   can	   be	   life	   threatening	   if	   it	   causes	  
swelling	  of	  the	  larynx	  with	  obstruction	  of	  the	  airways.	  
We	  describe	   the	   case	  of	   a	   52-­‐year-­‐old	  man	  who	  presented	   a	   neurological	   emergency	   (coma),	  where	   the	   remarkable	  
localization	  of	  the	  clinical	  manifestation	  and	  the	  unusual	  symptomatology	  hindered	  the	  correct	  diagnosis.	  
	   	  
	  






Case	  report	   	  
A	   52-­‐year-­‐old	   man	   had	   headaches	   for	   two	   days.	   On	   the	   third	   day,	   he	   presented	   with	   transient	   mental	   confusion,	  
dysarthria	   and	   dysmetria	   and	   came	   to	   the	   hospital	   emergency	   room	   (ER).	   He	   presented	  with	   numbness	   and	   loss	   of	  
consciousness:	  first-­‐degree	  coma	  was	  diagnosed.	  Haematochemical	  tests	  ruled	  out	  metabolic	  alterations.	  Glycerol	  was	  
administered	   as	   an	   anti-­‐oedema	   agent.	   A	   CT	   scan	   revealed	   the	   presence	   of	   marked	   cerebral	   oedema	   without	  
space-­‐occupying	   lesions	   or	   vascular	   involvement.	   Neurological	   symptoms	   worsened	   over	   the	   next	   12	   h	   despite	   the	  
anti-­‐oedema	   treatment.	   Coma	   progressed	   towards	   the	   second	   degree.	   The	   neurosurgical	   staff	   was	   alerted	   and	   a	  
magnetic	  resonance	  imaging	  (MRI)	  (Figs.	  1	  and	  2)	  scan	  with	  contrast	  was	  performed.	  The	  presence	  of	  the	  oedema	  was	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As	   the	   symptoms	  could	  be	  attributed	   to	   toxic	  external	   causes,	   the	  emergency	  department	  and	  poison	  control	   centre	  
were	   alerted.	   The	   ER	   personnel	   gathered	   the	   information	   that	   the	   patient	   was	   a	   carrier	   for	   the	   genetic	   disorder	  
hereditary	  angioedema	  (HAE).	  Prompt	  i.v.	  administration	  of	  two	  C1	  esterase	  inhibitor	  (C1-­‐INH)	  boluses	  (Berinert	  10	  ml	  
Mix2VialTM,	  CSL	  Behring,	  Australia)	  drastically	  improved	  the	  patient’s	  condition:	  the	  symptoms	  began	  to	  dissipate	  after	  4	  
h,	  and	  he	  was	  revived	  from	  the	  coma	  after	  12	  h;	  the	  symptoms	  completely	  disappeared	  in	  48	  h.	  
	  
Discussion	  
HAE	  is	  a	  rare	  disorder	  transmitted	  as	  an	  autosomal	  dominant	  trait.	  The	  disease	  is	  disabling	  and	  can	  be	  lethal.	  The	  clinical	  
manifestations	   of	   HAE	   are	   self-­‐limiting	   episodic	   bouts	   of	   well-­‐circumscribed	   and	   non-­‐itching	   swelling	   of	   the	   deep	  
cutaneous,	   subcutaneous,	   submucosal	   and	   subepithelial	   tissues	   lasting	   2–5	   days.	   Oedema	   caused	   by	   HAE	   is	   dense,	  
aching	  and	  not	  compressible;	  mostly	  affects	   the	  skin	  and	  bowel	  and	  can	   induce	  swelling	  of	  genitalia.	  Oedema	  can	  be	  
life-­‐threatening	  if	  it	  causes	  swelling	  of	  the	  larynx	  with	  obstruction	  of	  the	  airways	  [1–5].	  
We	   know	   three	   forms	   of	   this	   condition:	   Type	   I	   HAE,	   which	   is	   characterized	   by	   impaired	   synthesis	   and	   low	   plasma	  
concentration	  of	  a	   functionally	  active	  C1-­‐INH;	  Type	   II	  HAE,	  which	   is	  characterized	  by	  a	  dysfunctional	  C1-­‐INH	  molecule	  
that	  is	  synthesized	  in	  normal	  amounts	  (HAE	  is	  diagnosed	  when	  the	  C1-­‐INH	  level	  is	  lower	  than	  50%	  of	  normal);	  and	  Type	  
III	  HAE,	  which	  is	  characterized	  by	  normal	  complement	  levels,	  but	  this	  can	  be	  caused	  by	  factor	  XII	  gene	  mutations	  [5].	   	  
C1-­‐INH	  inhibits	  components	  of	  the	  complement,	  contact	  (factor	  XII	  and	  kallicrein),	  coagulation	  (factor	  XI	  and	  thrombin)	  
Figure	   1.	   Contrast-­‐enhanced	   MR	   image	   (T2)	   during	   the	   course	   of	  
angioedema	   with	   partial	   effacement	   of	   cerebral	   sulci	   without	   midline	  
shift.	  
Figure	  2.	  Contrast-­‐enhanced	  MR	   image	  (T2)	  showing	  the	   lateral	  
ventricles.	   	  
	  
 	  
Doi:	  10.12890/2014_000092	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   European	  Journal	  of	  Case	  Reports	  in	  Internal	  Medicine	   	  
	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   ©	  EFIM	  2014	  
and	  fibrinolytic	  system	  and	  regulates	  the	  generation	  of	  vasoactive	  peptides,	  of	  which	  bradykinin	  is	  considered	  the	  most	  
important.	   Current	   therapeutic	   management	   consists	   in	   purified	   C1-­‐INH	   concentrate	   or	   in	   peripheral	   bradykinin	  
inhibitor	  [5].	  
This	  unusual	  case	  describes	  a	  neurological	  emergency	  consisting	  of	  a	  comatose	  state	  caused	  by	  cerebral	  oedema.	   	  
Cerebral	  localization	  of	  angioedema	  is	  certainly	  unusual	  and	  it	  seems	  to	  have	  been	  reported	  only	  once	  in	  the	  literature	  
[6].	  However,	  the	  vasodilation	  induced	  by	  C1	  inhibitor	  deficiency	  and	  accumulation	  of	  bradykinin	  can	  theoretically	  give	  
rise	   to	   oedema	   in	   any	   perivascular	   tissue.	   It	   is	   also	   known	   that,	   generally,	   the	  oedema	  may	  occur	  where	   pressure	   is	  
applied	  or	  trauma	  occurs.	  However,	  it	  supervenes	  very	  often	  without	  any	  apparent	  cause	  in	  the	  absence	  of	  trauma	  or	  
pressure	  [1–5].	  Brain	  oedema	  can	  be	  triggered	  by	  other	  unknown	  causes.	  
HAE	   may	   constitute	   a	   neurological	   emergency.	   This	   unusual	   case	   shows	   a	   neurological	   emergency	   consisting	   of	   a	  
comatose	  state	  caused	  by	  cerebral	  oedema.	  Only	  the	  correct	  diagnosis	  of	  the	  disorder	  and	  specific	  C1	  esterase	  inhibitor	  
replacement	  therapy	  was	  able	  to	  resolve	  the	  symptoms.	  
In	  our	  case,	  correct	  diagnosis	  of	  the	  clinical	  picture	  simulating	  a	  stroke	  and	  appropriate	  treatment	  were	  the	  result	  of	  a	  
careful	   history.	   Neither	   Nuclear	   Magnetic	   Resonance	   (NMR)	   nor	   the	   anti-­‐oedema	   treatment	   facilitated	   diagnosis	   or	  
improved	  outcome.	   In	  contrast,	  documentation	  of	  the	  patient’s	  case	  history	  and	  pathophysiological	  analysis	  ruled	  out	  
other	   possible	   underlying	   organic	   causes	   and	   led	   to	   the	   administration	   of	   the	   only	   therapy	   capable	   of	   resolving	   the	  
clinical	  picture.	  
Therefore,	   it	   is	   always	   appropriate	   to	   prolong	   observation	   and	   to	   collect	   a	   more	   accurate	   history	   from	   patients	   or	  
relatives	  in	  emergency	  cases	  presenting	  conflicting	  symptoms.	  
Finally,	  we	  recommend	  that	  patients	  with	  HAE	  should	  always	  carry	  a	  record	  of	  the	  diagnosis	  and	  emergency	  treatment	  




• HAE	  can	  mimic	  neurological	  emergency.	  
• HAE	  is	  potentially	  fatal.	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